Pillstats
Rx only · Injection · Intravenous

Technetium Tc 99m Sestamibi

Tetrakis(2-Methoxyisobutylisocyanide)copper(i) Tetrafluoroborate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)1537341
US makers1 labelers
Packages2
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.0K3.9K5.9K7.8K2025 Q32025 Q42026 Q1
6.8K
Rx · 2026 Q1
11K
Units dispensed
3
Quarters · since 2025 Q3

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Curium US LLCunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 26, 2024
    RECALLRecall (Class II): Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic react…

    Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product — Recalling firm: Curium US, LLC — Nationwide USA and Canada.